Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 270 followers
Latest posts
Last updated about 10 hours ago
Mendaera grabs $73M for handheld, needle-based robotics system
about 11 hours ago
Mendaera grabs $73M for handheld, needle-based robotics system chale Fri, 09/27/2024 -...
Cassava, former execs ink SEC deal to resolve allegations around misleading Alzheimer's data drop
about 14 hours ago
Cassava, former execs ink SEC deal to resolve allegations around misleading Alzheimer's...
FDA lifts hold on diabetes trials after Biomea mitigates liver toxicity risk
about 17 hours ago
FDA lifts hold on diabetes trials after Biomea mitigates liver toxicity risk...
Chutes & Ladders—Acadia brings BMS vet on board as CEO
1 day ago
Chutes & Ladders—Acadia brings BMS vet on board as CEO dincorvaia Thu...
Repair licenses Genevant’s nucleic acid delivery tech for up to $107M per cardio product
1 day ago
Repair licenses Genevant’s nucleic acid delivery tech for up to $107M per...
Medtronic, Siemens Healthineers team up on spine surgery imaging
1 day ago
Medtronic, Siemens Healthineers team up on spine surgery imaging chale Thu, 09/26/2024...
Arch Venture closes $3B-plus fund as biotech investment environment shows more signs of a revival
1 day ago
Arch Venture closes $3B-plus fund as biotech investment environment shows more signs...
AbbVie's dopamine-focused Parkinson's treatment reduces disease burden in phase 3 trial
1 day ago
AbbVie's dopamine-focused Parkinson's treatment reduces disease burden in phase 3 trial dincorvaia...
Biogen cans SAGE-324 collaboration after essential tremor fail
1 day ago
Biogen cans SAGE-324 collaboration after essential tremor fail ntaylor Thu, 09/26/2024 -...
Enanta’s RSV antiviral crushes viral load in challenge study
1 day ago
Enanta’s RSV antiviral crushes viral load in challenge study ntaylor Thu, 09/26/2024...
Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end
1 day ago
Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big...
BioAge brings in almost $200M from IPO as obesity biotech joins Nasdaq
1 day ago
BioAge brings in almost $200M from IPO as obesity biotech joins Nasdaq...